Bain Capital Life Sciences IV

United States
Seed
Share

About Bain Capital Life Sciences IV

Bain Capital Life Sciences IV is a venture capital firm based in United States, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Biotech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionUnited States
Funding StageSeed
Industry Focus
Biotech
Saas

Investor Signals Profile

active

Sweet Spot

Visionary founder, seed-to-scale, tech or life sciences

Growth & Venture
Life Sciences
Crypto
Tech Opportunities
Real Assets & CRE

Bullish Signals

Global platform: PE, VC, Credit, Real Assetsexternal
New Abu Dhabi office opened April 2026external
40+ year track record, multi-strategyexternal
Active Life Sciences exits & launchesexternal
Healthcare AI Summit hosted; deep convictionlinkedin
New healthcare PE hire: Michael Horowitztwitter
Australia PE expansion: WealthPerpetual acquisitiontwitter
Active European PE deals: Tingstad investmenttwitter
Tech Opportunities team active post-sellofftwitter
Real Estate team hosts 100-student CRE summitlinkedin

Contrarian Signals

Mega-fund — small checks unlikelyexternal
Complex platform; long decision cyclesexternal
Broad mandate dilutes VC focusexternal
Heavy PE/credit focus; VC secondarytwitter

Founder Do's

Show seed-to-scale growth potential
Bring deep sector expertise
Align on long-term value creation
Demonstrate sustainability awareness
Leverage cross-platform collaboration fit

Founder Don'ts

Avoid short-term exit narratives
Don't ignore ESG/impact angle
No niche without scalable vision

Key GPs & Partners

CG
Chris Gordon
Partner
Private EquityValue Creation
PM
Paul Moskowitz
Partner
Private EquityValue Creation
AS
Amrita Sankar
Director
SustainabilityImpactESG
RC
Ryan Cotton
Partner
Real EstateCRELeadership
DG
David Gross
Partner
Private MarketsSector ExpertiseCapital Flexibility
JWD
Jennifer Wilson Davis
Partner
Private EquityPortfolio GrowthLeadership
DA
Darren Abrahamson
Partner
TechSoftwarePrivate Equity
JL
Jonathan Lavine
Partner
AI InvestingPrivate CreditGlobal PE
MH
Michael Horowitz
Partner
HealthcareSpecial SituationsNorth America
JW
John Wright
Partner
CreditAsset-Based FinanceGlobal
RM
Rafael Mason
Partner
DEIFinance AccessMentorship
MT
Marc Touboul
Partner
CreditEuropean MarketsCLOs
AR
Angelo Rufino
Partner
CreditAsset-Based FinanceBloomberg
TM
Tom Maughan
Partner
Private CreditUK MarketsSector Expertise

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

Fund Overview

Fund Size$3000M
Saves0

Key People

Matthew Calistri, Allyson Rinderle

Chris GordonPartner
Paul MoskowitzPartner
Amrita SankarDirector
Ryan CottonPartner
David GrossPartner
Jennifer Wilson DavisPartner
Darren AbrahamsonPartner
Jonathan LavinePartner
Michael HorowitzPartner
John WrightPartner
Rafael MasonPartner
Marc TouboulPartner
Angelo RufinoPartner
Tom MaughanPartner

Related Funds

BEX Fund V

$765M
United States
Seed
Enterprise Software
Fund Manager:Thomas Carbonel, Stephane Chevrier
Seed
Enterprise Software

Eclipse Ventures Fund VI

$720M
United States
Seed
Ai Ml, Robotics Automation, Manufacturing, Semiconductors
Fund Manager:Lior Susan
Seed
Ai Ml
Robotics Automation
Manufacturing
Semiconductors

Musa Capital Fund I

$15M
United States
Pre Seed
Ai Ml, Saas
Fund Manager:Allen Smith
Pre Seed
Ai Ml
Saas